Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.22.4
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Preferred Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Non-Controlling Interest
Beginning balance, common (in shares) at Mar. 31, 2021 [1]   89,790,086            
Beginning balance at Mar. 31, 2021 [1] $ 145,112 $ 10 $ 100 $ (71) $ 373,310 $ (903) $ (227,334) $ 0
Beginning balance, preferred (in shares) at Mar. 31, 2021 [1]     100,000          
Beginning balance, treasury (in shares) at Mar. 31, 2021 [1]       758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) [1] 14,253           14,284 (31)
Foreign currency translation [1] (20,781)         (20,019)   (762)
Stock-based compensation expense [1] 3,705       3,705      
Shares issued:                
Exercise of stock options (in shares) [1]   178,127            
Exercise of stock options [1] 695       695      
Issuance of restricted shares and vesting of restricted units (in shares) [1]   207,758            
Shares for acquisition of Fyber (in shares) [1]   4,716,935            
Shares for acquisition of Fyber [1] 359,233       359,233      
Acquisition of non-controlling interests in Fyber [1] 24,558             24,558
Ending balance, common (in shares) at Jun. 30, 2021 [1]   94,892,906            
Ending balance at Jun. 30, 2021 [1] 526,775 $ 10 $ 100 $ (71) 736,943 (20,922) (213,050) 23,765
Ending balance, preferred (in shares) at Jun. 30, 2021 [1]     100,000          
Ending balance, treasury (in shares) at Jun. 30, 2021 [1]       758,125        
Beginning balance, common (in shares) at Mar. 31, 2021 [1]   89,790,086            
Beginning balance at Mar. 31, 2021 [1] 145,112 $ 10 $ 100 $ (71) 373,310 (903) (227,334) 0
Beginning balance, preferred (in shares) at Mar. 31, 2021 [1]     100,000          
Beginning balance, treasury (in shares) at Mar. 31, 2021 [1]       758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) [2] 15,428              
Foreign currency translation [2] (45,062)              
Ending balance, common (in shares) at Dec. 31, 2021 [1]   96,731,227            
Ending balance at Dec. 31, 2021 [1] 485,866 $ 10 $ 100 $ (71) 740,592 (45,051) (211,888) 2,174
Ending balance, preferred (in shares) at Dec. 31, 2021 [1]     100,000          
Ending balance, treasury (in shares) at Dec. 31, 2021 [1]       758,125        
Beginning balance, common (in shares) at Jun. 30, 2021 [1]   94,892,906            
Beginning balance at Jun. 30, 2021 [1] 526,775 $ 10 $ 100 $ (71) 736,943 (20,922) (213,050) 23,765
Beginning balance, preferred (in shares) at Jun. 30, 2021 [1]     100,000          
Beginning balance, treasury (in shares) at Jun. 30, 2021 [1]       758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) [1] (5,887)           (5,852) (35)
Foreign currency translation [1] (15,892)         (15,799)   (93)
Stock-based compensation expense [1] 5,925       5,925      
Shares issued:                
Exercise of stock options (in shares) [1]   480,422            
Exercise of stock options [1] 1,460       1,460      
Issuance of restricted shares and vesting of restricted units (in shares) [1]   28,477            
Shares for acquisition of Fyber (in shares) [1]   1,058,364            
Shares for acquisition of Fyber [1] (2,547)       (2,547)      
Acquisition of non-controlling interests in Fyber [1] (21,452)             (21,452)
Ending balance, common (in shares) at Sep. 30, 2021 [1]   96,460,169            
Ending balance at Sep. 30, 2021 [1] 488,382 $ 10 $ 100 $ (71) 741,781 (36,721) (218,902) 2,185
Ending balance, preferred (in shares) at Sep. 30, 2021 [1]     100,000          
Ending balance, treasury (in shares) at Sep. 30, 2021 [1]       758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 7,062 [2]           7,014 [1] 48
Foreign currency translation (8,389) [1]         (8,330) [1]   (59)
Stock-based compensation expense [1] 5,739       5,739      
Shares issued:                
Exercise of stock options (in shares) [1]   201,015            
Exercise of stock options [1] 659       659      
Issuance of restricted shares and vesting of restricted units (in shares) [1]   70,043            
Payment of withholding taxes related to the net share settlement of equity awards [1] (7,587)       (7,587)      
Ending balance, common (in shares) at Dec. 31, 2021 [1]   96,731,227            
Ending balance at Dec. 31, 2021 [1] $ 485,866 $ 10 $ 100 $ (71) 740,592 (45,051) (211,888) 2,174
Ending balance, preferred (in shares) at Dec. 31, 2021 [1]     100,000          
Ending balance, treasury (in shares) at Dec. 31, 2021 [1]       758,125        
Beginning balance, common (in shares) at Mar. 31, 2022 97,163,701 97,163,701 [1]            
Beginning balance at Mar. 31, 2022 [1] $ 516,215 $ 10 $ 100 $ (71) 745,661 (39,341) (191,788) 1,644
Beginning balance, preferred (in shares) at Mar. 31, 2022 100,000   100,000 [1]          
Beginning balance, treasury (in shares) at Mar. 31, 2022 758,125     758,125 [1]        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) [1] $ 14,958           14,922 36
Foreign currency translation [1] (5,542)         (5,749)   207
Stock-based compensation expense [1] 6,463       6,463      
Shares issued:                
Exercise of stock options (in shares) [1]   380,176            
Exercise of stock options [1] 296       296      
Issuance of restricted shares and vesting of restricted units (in shares) [1]   7,763            
Shares for acquisition of Fyber (in shares) [1]   1,205,982            
Shares for acquisition of Fyber [1] 50,000       50,000      
Payment of withholding taxes related to the net share settlement of equity awards [1] (4,357)       (4,357)      
Ending balance, common (in shares) at Jun. 30, 2022 [1]   98,757,622            
Ending balance at Jun. 30, 2022 [1] $ 578,033 $ 10 $ 100 $ (71) 798,063 (45,090) (176,866) 1,887
Ending balance, preferred (in shares) at Jun. 30, 2022 [1]     100,000          
Ending balance, treasury (in shares) at Jun. 30, 2022 [1]       758,125        
Beginning balance, common (in shares) at Mar. 31, 2022 97,163,701 97,163,701 [1]            
Beginning balance at Mar. 31, 2022 [1] $ 516,215 $ 10 $ 100 $ (71) 745,661 (39,341) (191,788) 1,644
Beginning balance, preferred (in shares) at Mar. 31, 2022 100,000   100,000 [1]          
Beginning balance, treasury (in shares) at Mar. 31, 2022 758,125     758,125 [1]        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) [2] $ 30,723              
Foreign currency translation [2] $ (4,644)              
Shares issued:                
Exercise of stock options (in shares) 895,450              
Ending balance, common (in shares) at Dec. 31, 2022 99,143,203 99,143,203 [1]            
Ending balance at Dec. 31, 2022 [1] $ 607,627 $ 10 $ 100 $ (71) 810,994 (44,201) (161,183) 1,978
Ending balance, preferred (in shares) at Dec. 31, 2022 100,000   100,000 [1]          
Ending balance, treasury (in shares) at Dec. 31, 2022 758,125     758,125 [1]        
Beginning balance, common (in shares) at Jun. 30, 2022 [1]   98,757,622            
Beginning balance at Jun. 30, 2022 [1] $ 578,033 $ 10 $ 100 $ (71) 798,063 (45,090) (176,866) 1,887
Beginning balance, preferred (in shares) at Jun. 30, 2022 [1]     100,000          
Beginning balance, treasury (in shares) at Jun. 30, 2022 [1]       758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) [1] 11,703           11,664 39
Foreign currency translation [1] (9,246)         (9,239)   (7)
Stock-based compensation expense [1] 6,142       6,142      
Shares issued:                
Exercise of stock options (in shares) [1]   198,778            
Exercise of stock options [1] 643       643      
Issuance of restricted shares and vesting of restricted units (in shares) [1]   29,035            
Payment of withholding taxes related to the net share settlement of equity awards [1] (1,572)       (1,572)      
Ending balance, common (in shares) at Sep. 30, 2022 [1]   98,985,435            
Ending balance at Sep. 30, 2022 [1] 585,703 $ 10 $ 100 $ (71) 803,276 (54,329) (165,202) 1,919
Ending balance, preferred (in shares) at Sep. 30, 2022 [1]     100,000          
Ending balance, treasury (in shares) at Sep. 30, 2022 [1]       758,125        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) [1] 4,062           4,019 43
Foreign currency translation [1] 10,144         10,128   16
Stock-based compensation expense [1] 7,835       7,835      
Shares issued:                
Exercise of stock options (in shares) [1]   84,594            
Exercise of stock options [1] 156       156      
Issuance of restricted shares and vesting of restricted units (in shares) [1]   73,174            
Payment of withholding taxes related to the net share settlement of equity awards [1] $ (273)       (273)      
Ending balance, common (in shares) at Dec. 31, 2022 99,143,203 99,143,203 [1]            
Ending balance at Dec. 31, 2022 [1] $ 607,627 $ 10 $ 100 $ (71) $ 810,994 $ (44,201) $ (161,183) $ 1,978
Ending balance, preferred (in shares) at Dec. 31, 2022 100,000   100,000 [1]          
Ending balance, treasury (in shares) at Dec. 31, 2022 758,125     758,125 [1]        
[1] In the fiscal quarter ended June 30, 2021, the Company initiated two significant acquisitions. Please refer to Note 3, “Acquisitions,” in the accompanying condensed consolidated financial statements.
[2] In the fiscal quarter ended June 30, 2021, the Company initiated two significant acquisitions. Please refer to Note 3, “Acquisitions,” in the accompanying condensed consolidated financial statements.